Editorial: Targeting the Chemoattractant System in Inflammation

Front Pharmacol. 2021 Aug 16:12:744290. doi: 10.3389/fphar.2021.744290. eCollection 2021.

Tadashi Hosoya¹, Dunai Cordelia^{2

3}, Benedict D Michael^{2

3

4}, Chie Miyabe⁵, Jun Nagai^{6

7}, Thomas T Murooka⁸, Yoshishige Miyabe⁹

¹ Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Liverpool, United Kingdom.
² Clinical Infection Microbiology and Immunology, Institute of Infection Ecology and Veterinary Sciences, University of Liverpool, Liverpool, United Kingdom.
³ NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, United Kingdom.
⁴ The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
⁵ Division of Dermatology, Tokyo Women's Medical University, Chiba, Japan.
⁶ Department of Medicine, Harvard Medical School, Boston, MA, United States.
⁷ Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, United States.
⁸ Department of Immunology, University of Manitoba, Winnipeg, MB, Canada.
⁹ Department of Cell Biology, Nippon Medical School, Institute for Advanced Medical Sciences, Tokyo, Japan.

No abstract available

Keywords: chemokine; complement; immunology; inflammation; lipid mediator.

Publication types